In two parallel pragmatic equivalence trials, leukotriene receptor antagonists as initial therapy for asthma compared with inhaled corticosteroids and as add on therapy to ICS compared with adding long-acting β agonists provided equivalent short-term asthma quality of life but were associated with more medication switches.

J Mark FitzGerald

In two parallel pragmatic equivalence trials, leukotriene receptor antagonists as initial therapy for asthma compared with inhaled corticosteroids and as add on therapy to ICS compared with adding long-acting β agonists provided equivalent short-term asthma quality of life but were associated with more medication switches.

2012

J Mark FitzGerald

Commentary on: D Price, SD Musgrave, L Shepstone, et al.. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med2011;364:1695–707.

Keywords:

Physical therapy
Leukotriene Antagonists
Diabetes mellitus
Leukotriene Receptor Antagonists
Asthma
Quality of life
Medicine
inhaled corticosteroids
initial therapy
long acting β agonists
add on therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations